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See Article, pages 856–862Ascites develops in 5–10% of patients with compensated cirrhosis
per year and carries an ominous prognosis [1]. The appropriate
management and possible prevention of this complication obvi-
ously depends on an in-depth knowledge of ascites pathophysiol-
ogy, which remains somewhat elusive despite many studies that
have addressed the topic over decades. There is no doubt that
post-sinusoidal portal hypertension is the main ‘‘local” pathoge-
netic factor, and renal sodium retention is the main ‘‘systemic”
event leading to a positive ﬂuid balance and, ultimately, ascites
formation. However, uncertainties surround both the efferent
(that is the factors/systems promoting renal sodium retention)
and afferent (that is the factors that activate efferent mecha-
nisms) factors associated with renal sodium handling abnormal-
ities [2]. Sodium balance has been demonstrated to become
positive before ascites formation both in animal models of cirrho-
sis and humans [3–6]. Study of the early mechanisms leading to
ascites would help unveil its pathophysiology in a stage of the
disease where further complications involving systemic hemody-
namics and renal function may act as confounding factors. In this
issue of the Journal of Hepatology, Sansoè and co-workers pres-
ent a ﬁne study on an efferent mechanism potentially leading
to renal sodium retention in pre-ascitic cirrhosis [7].
It has been convincingly demonstrated, both in animal models
of cirrhosis and patients, that pre-ascitic renal sodium retention
occurs while the glomerular ﬁltration rate is well-preserved, indi-
cating that sodium handling abnormalities reside at the tubular
level [3–6]. Micropuncture studies performed in dogs with
dimethylnitrosamine-induced cirrhosis showed that sodium
resorption by the proximal convoluted tubule and hence sodium
delivery to the more distal nephron segments are not impaired
[3]. This demonstrates that sodium retention occurs beyond the
proximal convoluted tubule, and implies that both Henle’s loop
and the collecting duct could be involved.
In line with the hypothesis that the collecting duct, the aldo-
sterone-sensitive portion of the nephron, is the main site of
sodium retention, is the demonstration that a progressive
increase in positive sodium balance paralleled an increase inJournal of Hepatology 20
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induced cirrhosis [4]. Even more compelling evidence in favour
of a central role of hyperaldosteronism was provided by fully
preventing renal sodium retention and ascites formation with
the administration of the aldosterone antagonist spironolactone
[4]. Data from humans appear to agree with these ﬁndings. The
distal fractional tubular resorption of sodium was found to be
increased and critical in regulating both central ﬂuid volume
and sodium excretion [8]. It is noteworthy that sodium retention
in patients only occurs in the erect posture, whereas natriuresis
ensues while supine [5,9]. In standing patients, renal sodium
excretion is inversely correlated with plasma aldosterone con-
centration, which is only slightly increased [5]. Given the hyper-
bolic relationship between these variables, even subtle changes
in aldosterone secretion can induce substantial changes in natri-
uresis. Moreover, the supine-induced increase in renal sodium
excretion was exactly predictable, based on the parallel changes
in plasma aldosterone concentration [5]. The role of aldosterone
in promoting positive sodium balance and, hence, plasma volume
expansion in patients with pre-ascitic cirrhosis is also supported
by the effect of aldosterone antagonists: spironolactone lowers
plasma volume [10] and chronic K-canrenoate administration
reduces the occurrence of a combined end-point such as progres-
sion of esophageal varices and/or onset of ascites in compen-
sated patients [11]. Further studies in human cirrhosis conﬁrmed
that erect posture-related renal sodium retention occurs at the
distal nephron. However, they indicated that the proximal tubule
is also involved, likely because of the selective activation of the
intrarenal renin-angiotensin system [6,12]. In fact, the systemic
renin-angiotensin system was not activated and low-dose Losar-
tan, an angiotensin II receptor antagonist, prevented the upright-
induced renal sodium retention.
Taken together, these studies appear to indicate that distal,
aldosterone-dependent, and proximal, angiotensin II-dependent
sodium retention are the main mechanisms leading to extracellu-
lar volume expansion in patients with pre-ascitic cirrhosis. This
scenario, however, is not devoid of shadows. The main criticism
of the role of aldosterone derives from the ﬁnding that, in certain
experimental conditions, sodium balance can be positive even
with normal plasma aldosterone concentration. The striking
effect of posture on the renin-aldosterone axis explains why
supine patients with pre-ascitic cirrhosis exhibit normal or even10 vol. 53 j 790–792
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depressed plasma aldosterone concentrations [5]. However, this
cannot apply to quadrupeds like dogs [3]. Thus, attention shifted
to a hitherto neglected portion of the nephron: the loop of Henle.
By assaying the natriuretic efﬁciency of Furosemide in rats with
bile-duct ligation, Jonassen et al. [13] provided indirect evidence
for an increased activity of the bumetanide-sensitive Na+K+2Cl
symporter (BSC-1) located in the luminal membrane of epithelial
cells lining the thick ascending limb (TAL) of Henle’s loop, which
appeared to be hypertrophic. These ﬁndings were conﬁrmed in
CCl4-induced cirrhosis [14], suggesting that increased sodium
chloride resorption at the loop of Henle contributes to the early
sodium retention that precedes ascites formation. Consistently,
immunoblotting of renal sodium transporters or channels in cir-
rhotic rats revealed an increase in many of them, including BSC-1
[15]. However, the abundance of aldosterone-sensitive transport
proteins was also markedly increased.
Sansoè et al. adopted a different approach to evaluate Henle’s
loop function in pre-ascitic cirrhosis [16]. They employed calcium
infusion as a tool to gauge sodium handling in the TAL of Henle’s
loop, since hypercalcemia lowers sodium resorption through the
inhibition of BSC-1 with an effect resembling that of loop diuret-
ics. This effect is mediated by the activation of calcium-sensing
receptors (CaRs), whose molecular structure was identiﬁed in
1993 [17]. These members of family C of the G protein-coupled
receptors are expressed in many human tissues, namely the para-
thyroid glands, where they regulate PTH synthesis and secretion,
and kidney, where they inﬂuence electrolyte and water resorp-
tion [18]. All nephron segments express CaRs, with the possible
exception of glomeruli, but the effect of their stimulation is
mainly evident in the TAL of Henle’s loop, where it reduces
BSC-1 content, and the distal convoluted tubule, where it sup-
presses water channel expression [17,18]. The role of CaRs in
renal sodium handling in health and disease is not fully under-
stood. However, there are conditions where changes in CaRs
structure or function could play a role, such as type 5 Bartter syn-
drome and essential hypertension [18].
In patients with pre-ascitic cirrhosis, intravenous calcium load
decreased the fractional sodium resorption beyond the proximal
tubule, resulting in greater diuresis, natriuresis, and free water
clearance with respect to healthy controls [16]. As aldosterone-
driven potassium secretion was similar in patients and controls
and unaffected by calcium loading, the authors concluded that
sodium retention in cirrhotic patients had to occur in Henle’s
loop. In our view, however, the fact that the subjects were stud-
ied during prolonged supine posture, which is known to suppress
aldosterone and promote natriuresis in pre-ascitic cirrhosis [5],
likely inﬂuenced these results.
Sansoè et al. further assessed the activity of the calcium-
dependent diuretic system in experimental cirrhosis [7], evaluat-
ing renal function, hormonal status, renal prostaglandin E2 (PGE2)
excretion, and renal tissue concentrations of BSC-1 and CaRs in
rats with CCl4-induced cirrhosis in the pre-ascitic stage. They
found that the renal content of BSC-1 was increased, conﬁrming
previous ﬁndings [15], whereas that of CaRs was reduced. Then,
by administering the calcimimetic molecule poly-L-arginine they
found that diuresis, renal sodium excretion, and free water clear-
ance, which were reduced in cirrhotic rats, returned to normal.
Such an effect occurred without any change in the renin-aldoste-
rone axis or arginine-vasopressin levels and was associated with
an increase in renal blood ﬂow, likely promoted by an enhanced
PGE2 synthesis. Unfortunately, the calcimimetic drug was notJournal of Hepatology 201given to normal rats, so we cannot know whether the renal
responses seen in cirrhotic animals were enhanced, an effect that
would have strengthened the hypothesis that the CaRs/BSC-1
system plays a major role in pre-ascitic renal sodium retention.
In addition, the causes/mechanisms leading to CaRs downregula-
tion remain unexplained.
In conclusion, the mechanisms leading to extracellular ﬂuid
expansion in pre-ascitic cirrhosis are further complicated by the
addition of a new player: the BSC-1 at the ascending limb of
Henle’s loop. Like many other pathophysiological backgrounds
of disease, early renal sodium handling abnormalities of cirrhosis
appear to result from the interplay of several factors/systems,
including aldosterone, angiotensin II and still undeﬁned factors
inﬂuencing CaRs and BSC-1 expression, without forgetting the
potential roles of the sympathoadrenergic system [19] and pros-
taglandins [20]. As a consequence, almost all nephron segments
participate in sodium retention, even though a hierarchy between
them, if any, cannot be deﬁned as yet. Nevertheless, the new
ﬁndings on the role of BSC-1 and the possibility to suppress its
activity with poly-L-arginine is particularly appealing as this
molecule, besides natriuresis, also improved renal perfusion
and did not activate vasoconstrictor systems. On the other hand,
caution is required before translating the results obtained in
experimental animals to patients, also taking into account that
posture has a substantial inﬂuence on sodium retaining systems
and renal function.Conﬂict of interest
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